GLP-1 drugs linked to 11-fold higher regurgitation rate under anesthesia

New research presented at the Association of Anaesthetists Annual Meeting in Liverpool, UK (Sept. 16–18), and published in the journal Anaesthesia, shows that among patients undergoing surgical procedures under the care of an anesthetist, the rate of a complication known as regurgitation is 11 times higher among patients taking the new class of diabetes and obesity medications glucagon-like peptide-1 receptor agonists (GLP-1 RAs) than among patients not taking those drugs—although the absolute risk of this complication remains small.

≈